Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-11-30
DOI
10.3389/fphar.2019.01350
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword
- (2019) Karin H. Simons et al. Nature Reviews Cardiology
- BRIEF REPORT: Immune checkpoint inhibitor associated pericarditis
- (2019) Mehmet Altan et al. Journal of Thoracic Oncology
- Cardiovascular toxicities associated with immune checkpoint inhibitors
- (2019) Jiun-Ruey Hu et al. CARDIOVASCULAR RESEARCH
- Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors
- (2019) changhua ji et al. CLINICAL CANCER RESEARCH
- Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases
- (2019) Suheil Albert Atallah-Yunes et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- PD-1 inhibitor-associated severe myasthenia gravis with necrotizing myopathy and myocarditis
- (2019) Hayato So et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Cardiac toxicity of immune-checkpoint inhibitors: a clinical case of nivolumab-induced myocarditis and review of the evidence and new challenges
- (2019) Roberto Martin Huertas et al. Cancer Management and Research
- Sequential Blockade of PD-1 and PD-L1 Causes Fulminant Cardiotoxicity—From Case Report to Mouse Model Validation
- (2019) Shin-Yi Liu et al. Cancers
- Combination Nivolumab/Ipilimumab Immunotherapy For Melanoma With Subsequent Unexpected Cardiac Arrest
- (2019) Zaid H. Khoury et al. JOURNAL OF IMMUNOTHERAPY
- Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy
- (2019) Khashayar Esfahani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
- (2019) Joe-Elie Salem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rare, but Severe: Vasculitis and Checkpoint Inhibitors
- (2019) Andrea Katharina Lindner et al. European Urology Focus
- Late-Onset Fulminant Myocarditis With Immune Checkpoint Inhibitor Nivolumab
- (2018) Shogo Yamaguchi et al. CANADIAN JOURNAL OF CARDIOLOGY
- Immune Checkpoint Inhibitor-Associated Myocarditis: A New Challenge for Cardiologists
- (2018) Mauro Frigeri et al. CANADIAN JOURNAL OF CARDIOLOGY
- Cardiac Complications Associated With Checkpoint Inhibition: A Systematic Review of the Literature in an Important Emerging Area
- (2018) Hassan Mir et al. CANADIAN JOURNAL OF CARDIOLOGY
- CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
- (2018) Ryuma Tokunaga et al. CANCER TREATMENT REVIEWS
- Cardiotoxicities Associated with Immune Checkpoint Inhibitors
- (2018) Shu Yang et al. CURRENT PROBLEMS IN CANCER
- Fatal autoimmune myocarditis with anti–PD-L1 and tyrosine kinase inhibitor therapy for renal cell cancer
- (2018) A.M. Berner et al. EUROPEAN JOURNAL OF CANCER
- Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: the role of occult pre-existing autoimmunity
- (2018) Nicolas Martinez-Calle et al. HAEMATOLOGICA
- Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring
- (2018) Yumi Katsume et al. INTERNAL MEDICINE
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Life-threatening Autoimmune Cardiomyopathy Reproducibly Induced in a Patient by Checkpoint Inhibitor Therapy
- (2018) Azadeh Tajmir-Riahi et al. JOURNAL OF IMMUNOTHERAPY
- Immune-mediated Pericarditis With Pericardial Tamponade During Nivolumab Therapy
- (2018) Daniel V.P. de Almeida et al. JOURNAL OF IMMUNOTHERAPY
- Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte Globulin
- (2018) Varun Jain et al. JOURNAL OF IMMUNOTHERAPY
- Cardiac Toxicity in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Carlo G. Tocchetti et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
- (2018) Javid J Moslehi et al. LANCET
- Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial
- (2018) Toni K Choueiri et al. LANCET ONCOLOGY
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action
- (2018) Tomas G. Neilan et al. ONCOLOGIST
- Immune Checkpoint Inhibitor‐Associated Myocarditis
- (2018) Sarju Ganatra et al. ONCOLOGIST
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Takotsubo-Like Syndrome in Cancer Patients Treated With Immune Checkpoint Inhibitors
- (2018) Stephane Ederhy et al. JACC-Cardiovascular Imaging
- Cardiotoxicity of Immunotherapy: Incidence, Diagnosis, and Management
- (2018) Aarti Asnani Current Oncology Reports
- Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: the role of occult pre-existing autoimmunity
- (2018) Nicolas Martinez-Calle et al. HAEMATOLOGICA
- Acute autoimmune myocarditis and hepatitis due to ipilimumab monotherapy for malignant melanoma
- (2018) Yazeed Samara et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Sick sinus syndrome associated with anti-programmed cell death-1
- (2018) Chien-Yi Hsu et al. Journal for ImmunoTherapy of Cancer
- Immune checkpoint inhibitors myocarditis: not all cases are clinically patent
- (2018) Constance Thibault et al. EUROPEAN HEART JOURNAL
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report
- (2018) Cecilia Monge et al. Journal for ImmunoTherapy of Cancer
- Immune checkpoint inhibitor-related myocarditis
- (2017) Kazuko Tajiri et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2017) Clyde W. Yancy et al. JOURNAL OF CARDIAC FAILURE
- Fatal Myocarditis Following Treatment with the PD-1 Inhibitor Nivolumab
- (2017) Daniel R. Matson et al. JOURNAL OF FORENSIC SCIENCES
- Myasthenia Gravis After Nivolumab Therapy for Squamous Cell Carcinoma of the Bladder
- (2017) Elaine Chang et al. JOURNAL OF IMMUNOTHERAPY
- Cardiac MR With Late Gadolinium Enhancement in Acute Myocarditis With Preserved Systolic Function
- (2017) Giovanni Donato Aquaro et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Case of Heart Failure after Treatment with Anti–PD-1 Antibody Followed by Adoptive Transfer of Cytokine-Activated Killer Cells in a Recurrent Lung Cancer Patient
- (2017) Hideki Kimura et al. Journal of Thoracic Oncology
- New-onset third-degree atrioventricular block because of autoimmune-induced myositis under treatment with anti-programmed cell death-1 (nivolumab) for metastatic melanoma
- (2017) Juliane Behling et al. MELANOMA RESEARCH
- Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan
- (2017) Shigeaki Suzuki et al. NEUROLOGY
- Supportive care for patients undergoing immunotherapy
- (2017) Bernardo Leon Rapoport et al. SUPPORTIVE CARE IN CANCER
- Cardiovascular Toxicities Associated with Cancer Immunotherapies
- (2017) Daniel Y. Wang et al. Current Cardiology Reports
- Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab
- (2017) Alexandre Reuben et al. OncoImmunology
- Pembrolizumab-induced myasthenia gravis: A fatal case report
- (2017) Katherine L March et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Smoldering myocarditis following immune checkpoint blockade
- (2017) Timothy G. Norwood et al. Journal for ImmunoTherapy of Cancer
- Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
- (2017) I. Puzanov et al. Journal for ImmunoTherapy of Cancer
- Plasma brain natriuretic peptide levels are elevated in patients with cancer
- (2017) Sachiko Bando et al. PLoS One
- Left Ventricular Dysfunction After Treatment With Ipilimumab for Metastatic Melanoma
- (2016) Mary E. Roth et al. AMERICAN JOURNAL OF THERAPEUTICS
- Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy
- (2016) S Bowyer et al. BRITISH JOURNAL OF CANCER
- Myasthenic crisis and polymyositis induced by one dose of nivolumab
- (2016) Toshihiro Kimura et al. CANCER SCIENCE
- Acute Lymphocytic Myocarditis With Anti-PD-1 Antibody Nivolumab
- (2016) Tomonori Tadokoro et al. Circulation-Heart Failure
- Application of Cardiac Troponin in Cardiovascular Diseases Other Than Acute Coronary Syndrome
- (2016) Kai M. Eggers et al. CLINICAL CHEMISTRY
- Noninvasive imaging in acute myocarditis
- (2016) Karan Bami et al. CURRENT OPINION IN CARDIOLOGY
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Apical takotsubo syndrome in a patient with metastatic breast carcinoma on novel immunotherapy
- (2016) Robert D. Anderson et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Drug-induced myocarditis after nivolumab treatment in a patient with PDL1- negative squamous cell carcinoma of the lung
- (2016) H. Semper et al. LUNG CANCER
- Efficacy of short-term nivolumab treatment in a Chinese patient with relapsed advanced-stage lung squamous cell carcinoma
- (2016) Guoliang Pi et al. MEDICINE
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
- (2016) Douglas B. Johnson et al. JAMA Oncology
- Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors
- (2016) Claire F. Friedman et al. JAMA Oncology
- Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
- (2016) Lucie Heinzerling et al. Journal for ImmunoTherapy of Cancer
- Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study
- (2016) Viktor H. Koelzer et al. Journal for ImmunoTherapy of Cancer
- Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
- (2015) S. Champiat et al. ANNALS OF ONCOLOGY
- Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity
- (2015) Michael Hughes et al. ANNALS OF THE RHEUMATIC DISEASES
- PD-1 Blockers
- (2015) Jedd D. Wolchok CELL
- Update on Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on QT Interval, Left Ventricular Dysfunction and Overall Risk/Benefit
- (2015) Rashmi R. Shah et al. DRUG SAFETY
- Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
- (2015) Abhisek Swaika et al. MOLECULAR IMMUNOLOGY
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy
- (2015) Mizuki Nishino et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
- (2015) Heinz Läubli et al. Journal for ImmunoTherapy of Cancer
- Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome
- (2015) Benjamin P Geisler et al. Journal for ImmunoTherapy of Cancer
- Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway
- (2014) Ole-Petter R. Hamnvik et al. CANCER
- Programmed Death Ligand 1 Regulates a Critical Checkpoint for Autoimmune Myocarditis and Pneumonitis in MRL Mice
- (2014) J. A. Lucas et al. JOURNAL OF IMMUNOLOGY
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
- (2013) A. L. P. Caforio et al. EUROPEAN HEART JOURNAL
- Ipilimumab-induced acute severe colitis treated by infliximab
- (2013) Cecile Pagès et al. MELANOMA RESEARCH
- The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
- (2013) Caroline J. Voskens et al. PLoS One
- Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
- (2012) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis
- (2012) M. L. Tarrio et al. JOURNAL OF IMMUNOLOGY
- Update on Myocarditis
- (2012) Ingrid Kindermann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alemtuzumab for Cytolytic Induction of Immunosuppression in Heart Transplant Recipients
- (2012) William D. Cahoon et al. Progress in Transplantation
- 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology
- (2011) Ornella Leone et al. CARDIOVASCULAR PATHOLOGY
- How to Interpret Elevated Cardiac Troponin Levels
- (2011) Vinay S. Mahajan et al. CIRCULATION
- The 10 commandments of troponin, with special reference to high sensitivity assays
- (2011) A. S. Jaffe HEART
- Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
- (2010) Ryosuke Hino et al. CANCER
- PD-1 deficiency results in the development of fatal myocarditis in MRL mice
- (2010) Jian Wang et al. INTERNATIONAL IMMUNOLOGY
- A novel real-time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnoses
- (2010) Harutaka Katano et al. JOURNAL OF MEDICAL VIROLOGY
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- (2009) Karl S. Peggs et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
- (2009) Matthias G. Friedrich et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mechanical Circulatory Support for Patients With Fulminant Myocarditis: The Role of Echocardiography To Address Diagnosis, Choice of Device, Management, and Recovery
- (2008) Emanuele Catena et al. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now